| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |